Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Eniola Odetunde/Axios
A team of researchers at the Johns Hopkins School of Public Health has some warnings about the pandemic causing drug shortages — and some ideas on what to do about it.
Driving the news: COVID is increasing the demand for drugs that are needed to treat patients with the virus — like sedatives and vasopressors, which help patients with low blood pressure, per the report.
- It's also shutting down the production of important medications, since China produces active pharmaceutical ingredients and it had to close down some of its factories because of the pandemic.
- And travel bans have created delays that have led to shortages of drugs like propofol, an anesthetic.
The report recommends several steps to address the problems, many of which involve expanding the authority of the FDA:
- Adding drugs to its shortage list, which would allow it to use strategies to increase manufacturing.
- Creating quality metrics for manufacturing. (Congress would have to authorize it, since not everyone agrees that the agency has the power to do this.)
- Creating an FDA database of approved manufacturers of active pharmaceutical ingredients.
- Requiring manufacturers to prove they have a stockpile of active pharmaceutical ingredients, and approving new drugs or manufacturing changes more quickly (both of which would have to be authorized by Congress).
The catch: Most of these recommendations rely pretty heavily on giving the FDA more regulatory power.
- That might not be a slam dunk with Republican lawmakers for anything Congress has to approve — although that might matter less now that Democrats are in control.